Pesky ‘Macro Factors’—aka RFK Jr.—Come for Vaccine Pharmas’ Wallets

Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all suffering revenue hits to their vaccine programs.